The Valley Desk

NCT05923190 · Interventional trial

Enfortumab Vedotin Schedule De-escalation in Metastatic Urothelial Carcinoma

Overall registry status Active not recruiting

Phase 2

Conditions Locally Advanced Urothelial Carcinoma, Metastatic Urothelial Carcinoma, Urothelial Carcinoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov